Commodore Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.4M | Buy |
+1,075,000
| New | +$59.4M | 4.19% | 9 |
|
|
2022
Q2 | – | Sell |
-331,886
| Closed | -$7.86M | – | 29 |
|
|
2022
Q1 | $7.86M | Sell |
331,886
-473,687
| -59% | -$11.2M | 1.76% | 19 |
|
|
2021
Q4 | $27.6M | Buy |
805,573
+307,494
| +62% | +$10.5M | 6.38% | 6 |
|
|
2021
Q3 | $8.83M | Buy |
498,079
+287,479
| +137% | +$5.09M | 2.33% | 18 |
|
|
2021
Q2 | $9.45M | Sell |
210,600
-139,000
| -40% | -$6.24M | 3.29% | 14 |
|
|
2021
Q1 | $9.06M | Buy |
349,600
+2,100
| +0.6% | +$54.4K | 3.61% | 9 |
|
|
2020
Q4 | $7.01M | Buy |
+347,500
| New | +$7.01M | 3.81% | 13 |
|